BACKGROUND: Circadian rhythm disturbance has been implicated in depression, and polymorphisms of circadian genes Cry1, Cry2, and Tef are associated with depression. However, the relationship between these genes and depression symptoms in Parkinson's disease (PD) has not been established. METHODS: Four hundred eight subjects with PD participated in this study. Demographics, UPDRS, Mini-Mental Status Examination (MMSE), and Hamilton Rating Scale for Depression (HAMD) were obtained in all subjects. Frequency of polymorphisms of Cry1 rs2287161, Cry2 rs10838524, and Tef rs738499 was determined, and the association between genetic polymorphisms of circadian genes and HAMD scores in patients with PD was examined. RESULTS: Tef, but not Cry1 or Cry2, is associated with HAMD scores in patients with PD in a linear regression model after adjusting for clinical variables (P = 0.004). CONCLUSIONS: The polymorphism of Tef rs738499 is associated with depression symptoms in PD.
BACKGROUND: Circadian rhythm disturbance has been implicated in depression, and polymorphisms of circadian genes Cry1, Cry2, and Tef are associated with depression. However, the relationship between these genes and depression symptoms in Parkinson's disease (PD) has not been established. METHODS: Four hundred eight subjects with PD participated in this study. Demographics, UPDRS, Mini-Mental Status Examination (MMSE), and Hamilton Rating Scale for Depression (HAMD) were obtained in all subjects. Frequency of polymorphisms of Cry1rs2287161, Cry2rs10838524, and Tefrs738499 was determined, and the association between genetic polymorphisms of circadian genes and HAMD scores in patients with PD was examined. RESULTS:Tef, but not Cry1 or Cry2, is associated with HAMD scores in patients with PD in a linear regression model after adjusting for clinical variables (P = 0.004). CONCLUSIONS: The polymorphism of Tefrs738499 is associated with depression symptoms in PD.
Authors: R Mössner; A Henneberg; A Schmitt; Y V Syagailo; M Grässle; T Hennig; R Simantov; M Gerlach; P Riederer; K P Lesch Journal: Mol Psychiatry Date: 2001-05 Impact factor: 15.992
Authors: Jennifer S A M Reijnders; Uwe Ehrt; Wim E J Weber; Dag Aarsland; Albert F G Leentjens Journal: Mov Disord Date: 2008-01-30 Impact factor: 10.338
Authors: C Marras; B Schüle; B Schuele; R P Munhoz; E Rogaeva; J W Langston; M Kasten; C Meaney; C Klein; P M Wadia; S-Y Lim; R S-I Chuang; C Zadikof; T Steeves; K M Prakash; R M A de Bie; G Adeli; T Thomsen; K K Johansen; H A Teive; A Asante; W Reginold; A E Lang Journal: Neurology Date: 2011-07-13 Impact factor: 9.910
Authors: Sarah D Linnstaedt; Yue Pan; Matthew C Mauck; Jenyth Sullivan; Christine Y Zhou; Lindsey Jung; Cathleen A Rueckeis; Jameson D Blount; Matthew S Carson; Andrew S Tungate; Michael C Kurz; Phyllis L Hendry; Christopher Lewandowski; Teresa D'Anza; Elizabeth Datner; Kathy Bell; Megan Lechner; Jeffrey W Shupp; Bruce A Cairns; Samuel A McLean Journal: Front Psychiatry Date: 2018-11-15 Impact factor: 4.157